This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Shyam Bishen, Head, Shaping the Future of Health and Healthcare, Member of Executive Committee, World Economic Forum, Kevin Doxzen, Hoffmann Fellow, Precision Medicine and Emerging Biotechnologies, World Economic Forum More than 110 years ago, a Chicago doctor observed […]Gene therapy: Why we need to accelerate global access to the world’s most expensive drugs
October 24, 2022 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Shyam Bishen, Head, Shaping the Future of Health and Healthcare, Member of Executive Committee, World Economic Forum, Kevin Doxzen, Hoffmann Fellow, Precision Medicine and Emerging Biotechnologies, World Economic Forum More than 110 years ago, a Chicago doctor observed […]4 agile ways policy-makers can advance precision medicine
March 7, 2022 by 1 Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Kevin Doxzen, Hoffmann Fellow, Precision Medicine and Emerging Biotechnologies, World Economic Forum, Landry Signé, Professor and managing director, Thunderbird School of Global Management & Diana Bowman, Associate Dean and Professor, ASU Law, Arizona State University A combination of […]Pharmaceuticals are present in almost all the world’s rivers, study finds
February 18, 2022 by 1 Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Douglas Broom, Senior Writer, Formative Content 80% of the world’s wastewater is discharged untreated into the environment.This is resulting in the drugs we use to improve health finding their way into our rivers.The concentration of pharmaceuticals in waterways […]Why transparency in drug pricing is more complicated than it seems
October 2, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Alexander Roediger, Chair, Oncology Platform of the European Federation of Pharmaceutical Industries and Associations Transparency has become a prominent topic in debates about healthcare, particularly when it comes to pharmaceutical policy. There is a loud call for transparent prices, […]First do no harm. Why healthcare needs to change
September 17, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Robert Metzke, Global Head of Sustainability, Philips If I’ve learned one thing working in the healthcare sector, it’s the earlier you can diagnose a disease, the better chance you have of curing it – or at least mitigating its […]Reduce costs, save lives: how healthcare data can help emerging economies
September 4, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Noella Bigirimana, Government Fellow, Rwanda Ministry of Health , World Economic Forum Emerging economies are projected to surpass mature economies in overall generation of data by 2020. The volume of healthcare data, one of the fastest growing segments of […]Concorde is a reminder that the only way for innovation is up
March 5, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Simon Freakley, Chief Executive Officer, AlixPartners I do not think I have ever met a child who is not fascinated with flying. When an airplane passes overhead and my own children look up at the sky, I can remember […]We can end TB right now. Here’s how
January 17, 2019 by Leave a Comment
This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum. Author: Paul Stoffels, Vice Chair of the Executive Committee and Chief Scientific Officer, Johnson & Johnson In 2014, the world experienced the first-ever major Ebola epidemic. Over the following two years, nearly 30,000 Ebola cases were reported. More than 11,000 […]The EU clears Bayer-Monsanto merger amid wide competition and environmental concerns
March 27, 2018 by Leave a Comment
Last week, the European Union formally gave its approval to Germany multinational company Bayer’s $62.5 billion acquisition of US-based Monsanto. Bayer AG, leader in the chemical and pharmaceutical industry, got one step closer to take over the world’s largest seed company, after agreeing to bolster BASF SE by selling to it seeds, pesticides and digital […]Is there a drug for every disease?
December 24, 2012 by Leave a Comment
Pharmaceutical firms in Europe have an awkward relation with their customers. The truth is that their selling prices and product licencing are directly or indirectly controlled by the buyers, that is governments, or government control health insurance schemes, offering almost free health services to citizens. As everybody knows governments are not only able to influence […]
